- ReadCoor received Chan-Zuckerberg funding to map cortical cells for the Human Cell Atlas using FISSEQ, aiming to reveal cell variation within tissue micro-environments.  
- A new “acoustically targeted chemogenetics” (ATAC) method uses ultrasound to open the blood–brain barrier and deliver engineered GPCRs to specific neurons, enabling non-invasive, drug-controlled memory formation in mice.  
- FDA-approved gene therapy Luxturna (AAV-RPE65) restores vision in inherited blindness at a list price of $850,000, with discussion of orphan-drug incentives and open-source manufacturing costs below $100 k.  
- Researchers introduced acoustic reporter genes that let ultrasound track gut microbes deep inside living mammals, potentially revolutionizing in-vivo microbiome monitoring.  
- Vulpine Designs’ “Geneticiser” project proposes an open-source molecular bioprinter kit to rival 3-D printing in cost, though technical details remain vague.  
- Channel members debated power budgets for multi-nozzle bio-inkjet systems, estimating 500 W–1 kW for 32 000-nozzle arrays and exploring custom MEMS printhead fabrication in Asia.  
- Conversations referenced a $1 k IVF concept leveraging stem-cell-derived gametes, alongside literature reviews on global ART trends from 2004-2013.  
- A Scientific American post on the “Sanskrit effect” claimed mantra memorization enlarges hippocampal regions; skeptics noted similarity to mindfulness-meditation grey-matter increases and cited critical meta-analyses.